EUVIMED · CrossrefZeitschrift
Current Opinion in Lipidology
ISSN 0957-9672 · Ovid Technologies (Wolters Kluwer Health)
Neueste Artikel
Current, novel and emerging lipid-lowering therapies in pediatric familial hypercholesterolemia
Oral PCSK9 inhibitors: closing the gap between potency and practicality
CRISPR therapy for dyslipidemia
Bridging the Atlantic: converging paths, diverging approaches: a comparative review of the 2025 European Society of Cardiology/European Atherosclerosis Society focused update and the 2026 American College of Cardiology/American Heart Association guideline on dyslipidaemia management
How lipoproteins shape smooth muscle plasticity and cell state trajectories in atherosclerosis
Coronary artery calcium scoring and coronary computed tomography angiography in familial hypercholesterolemia: current evidence and future directions
Editorial introductions
Cholesteryl ester transfer protein inhibition: from LDL lowering to dementia prevention
New frontiers in the care of hypercholesterolaemia
Editorial introduction
Premature atherosclerotic cardiovascular disease in the MENA region: economic impact, barriers to care, and policy recommendations for an escalating crisis
Emerging regulators of endothelial lipid metabolism in atherosclerosis
A JAK of two trades: beneficial or adverse effects of Janus kinase inhibition for plasma LDL-cholesterol and major adverse cardiovascular events in inflammatory bowel disease patients?
HDL and ASCVD: is high HDL-C protective, harmful, or simply misleading?
Editorial introductions
Beyond cellular distress: reframing GDF15 as a lipid-sensitive metabolic signal
Update on genetics of familial hypercholesterolemia
Editorial introduction
Genetic insights from Greenland: when geography, history and genomics converge
Ultra-processed foods and CKD: a review of evidence, limitations, and future directions
Future of angiopoietin-like protein 3 inhibitors as a therapeutic agent
The complex pro-atherosclerotic role of lipoprotein(a): a multiplicity of cellular targets
Are Lipoprotein(a) levels decreased in insulin resistance and type 2 diabetes?
The breadth and impact of the Global Lipids Genetics Consortium
Inflammation in atherosclerosis: a Big Idea that has underperformed so far
Effectiveness of cascade screening for elevated lipoprotein(a), an underdiagnosed family disorder
C-reactive protein, pharmacological treatments and diet: how to target your inflammatory burden
Familial hypercholesterolemia in children and the importance of early treatment
Lipid metabolism during pregnancy: consequences for mother and child
Basic and translational evidence supporting the role of TM6SF2 in VLDL metabolism
Jahrgänge
2026 · 432025 · 492024 · 482023 · 442022 · 542021 · 692020 · 632019 · 842018 · 862017 · 942016 · 1042015 · 1002014 · 892013 · 1002012 · 1032011 · 992010 · 1052009 · 1022008 · 1112007 · 1102006 · 1052005 · 882004 · 1172003 · 982002 · 1032001 · 1002000 · 991999 · 1021998 · 1001997 · 1071996 · 1151995 · 1051994 · 1061993 · 1051992 · 1041991 · 981990 · 107
EUVIMED